Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201102235889N1Phase 3Completed
Phase 3 trial of ketamine in pain and Nausea and Vomiting, sponsored by no sponsor. Primary endpoint: Analgesic effect of ketamine in painful ophthalmic surgery. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201102235889N1.